UBS Group’s TetraLogic Pharmaceuticals TLOG Stock Holding History
Bought
Maintained
Sold
Other funds holding TLOG
UBS Group's TLOG Position: Q4 2016 in Review
UBS Group sold out of TetraLogic Pharmaceuticals (TLOG) in Q4 2016, closing a stake of 27,299 shares — an estimated $4K sold.
UBS Group first reported a position in TLOG in Q4 2014 and held it in 8 quarters. The position peaked at $69K in Q4 2014. 3 funds tracked by Wall St. Rank hold TLOG as of Q4 2016.
- UBS Group reported no remaining TetraLogic Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
- UBS Group sold 27,299 TetraLogic Pharmaceuticals shares in Q4 2016, an estimated $4K.
- UBS Group first reported a position in TetraLogic Pharmaceuticals in Q4 2014 and held it in 8 quarters.
- UBS Group's TetraLogic Pharmaceuticals position peaked at $69K in Q4 2014.
- 3 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals as of Q4 2016.
Based on UBS Group's 13F filing for Q4 2016, filed 14 Feb 2017.